Copyright
©The Author(s) 2022.
World J Clin Oncol. Jun 24, 2022; 13(6): 529-539
Published online Jun 24, 2022. doi: 10.5306/wjco.v13.i6.529
Published online Jun 24, 2022. doi: 10.5306/wjco.v13.i6.529
Table 2 Serum carcinoembryonic antigen and response to treatment in responders and non-responders
| Serum CEA | Responders | Non-responders | P value |
| Median pre-treatment serum CEA | 8.87 (2-49.6) | 5.4 (1.7-36.01) | 0.527 |
| Median post-treatment serum CEA | 2.07 (1-8.7) | 11 (4.65-22.5) | 0.002 |
| P value | 0.001 | 0.06 |
- Citation: Anoop TM, Joseph P R, Soman S, Chacko S, Mathew M. Significance of serum carcinoembryonic antigen in metastatic breast cancer patients: A prospective study. World J Clin Oncol 2022; 13(6): 529-539
- URL: https://www.wjgnet.com/2218-4333/full/v13/i6/529.htm
- DOI: https://dx.doi.org/10.5306/wjco.v13.i6.529